Sunshine Biopharma (SBFM) Competitors $1.38 +0.04 (+2.59%) As of 03:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SBFM vs. ABVC, NRSN, COCP, PHIO, INAB, CLRB, ME, MBRX, UPXI, and IMNNShould you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include ABVC BioPharma (ABVC), NeuroSense Therapeutics (NRSN), Cocrystal Pharma (COCP), Phio Pharmaceuticals (PHIO), IN8bio (INAB), Cellectar Biosciences (CLRB), 23andMe (ME), Moleculin Biotech (MBRX), Upexi (UPXI), and Imunon (IMNN). These companies are all part of the "pharmaceutical products" industry. Sunshine Biopharma vs. ABVC BioPharma NeuroSense Therapeutics Cocrystal Pharma Phio Pharmaceuticals IN8bio Cellectar Biosciences 23andMe Moleculin Biotech Upexi Imunon Sunshine Biopharma (NASDAQ:SBFM) and ABVC BioPharma (NASDAQ:ABVC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends. Which has higher earnings and valuation, SBFM or ABVC? Sunshine Biopharma has higher revenue and earnings than ABVC BioPharma. ABVC BioPharma is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSunshine Biopharma$34.87M0.11-$4.51M-$150.88-0.01ABVC BioPharma$509.59K32.20-$10.52M-$0.47-2.21 Does the media prefer SBFM or ABVC? In the previous week, ABVC BioPharma had 2 more articles in the media than Sunshine Biopharma. MarketBeat recorded 3 mentions for ABVC BioPharma and 1 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 1.91 beat ABVC BioPharma's score of 0.46 indicating that Sunshine Biopharma is being referred to more favorably in the media. Company Overall Sentiment Sunshine Biopharma Very Positive ABVC BioPharma Neutral Do analysts rate SBFM or ABVC? Sunshine Biopharma currently has a consensus price target of $15.00, suggesting a potential upside of 983.03%. Given Sunshine Biopharma's stronger consensus rating and higher probable upside, equities analysts plainly believe Sunshine Biopharma is more favorable than ABVC BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sunshine Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ABVC BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, SBFM or ABVC? Sunshine Biopharma has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, ABVC BioPharma has a beta of 0.33, suggesting that its share price is 67% less volatile than the S&P 500. Do insiders & institutionals believe in SBFM or ABVC? 42.0% of Sunshine Biopharma shares are owned by institutional investors. Comparatively, 11.4% of ABVC BioPharma shares are owned by institutional investors. 0.1% of Sunshine Biopharma shares are owned by company insiders. Comparatively, 11.9% of ABVC BioPharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer SBFM or ABVC? Sunshine Biopharma received 2 more outperform votes than ABVC BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformSunshine BiopharmaOutperform Votes2100.00% Underperform VotesNo VotesABVC BioPharmaN/AN/A Is SBFM or ABVC more profitable? Sunshine Biopharma has a net margin of -12.82% compared to ABVC BioPharma's net margin of -1,619.65%. Sunshine Biopharma's return on equity of -17.89% beat ABVC BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets Sunshine Biopharma-12.82% -17.89% -14.25% ABVC BioPharma -1,619.65%-104.94%-56.81% SummarySunshine Biopharma beats ABVC BioPharma on 13 of the 17 factors compared between the two stocks. Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFM vs. The Competition Export to ExcelMetricSunshine BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.75M$6.74B$5.50B$7.98BDividend YieldN/A3.05%5.11%4.23%P/E Ratio-0.017.3622.6318.59Price / Sales0.11242.40398.09103.52Price / CashN/A65.8538.1834.62Price / Book0.006.506.724.27Net Income-$4.51M$143.41M$3.22B$248.18M7 Day Performance-10.65%2.04%1.58%1.47%1 Month Performance-33.41%6.96%4.09%3.96%1 Year Performance61.01%-2.51%16.05%5.57% Sunshine Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMSunshine Biopharma3.211 of 5 stars$1.39+2.6%$15.00+983.0%+54.3%$3.75M$34.87M-0.013Positive NewsABVCABVC BioPharma0.7598 of 5 stars$0.87+2.1%N/A-15.2%$13.77M$509,788.00-1.0130Earnings ReportGap DownNRSNNeuroSense Therapeutics1.1221 of 5 stars$1.00-3.2%N/A-27.4%$13.67MN/A-1.5610Short Interest ↓Negative NewsCOCPCocrystal Pharma2.4936 of 5 stars$1.34+1.9%$7.00+424.2%-4.4%$13.58MN/A-0.7210Gap UpPHIOPhio Pharmaceuticals2.5262 of 5 stars$2.83+3.7%$4.00+41.3%-69.4%$13.52MN/A-0.2610Upcoming EarningsINABIN8bio3.6078 of 5 stars$0.17+3.3%$6.00+3,510.1%-83.4%$13.51MN/A-0.2220Upcoming EarningsShort Interest ↓Gap UpCLRBCellectar Biosciences1.7394 of 5 stars$0.29-2.9%$12.50+4,207.4%-91.9%$13.37MN/A-0.1710News CoverageGap UpME23andMeN/A$0.50-35.3%N/A-95.0%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeMBRXMoleculin Biotech2.9511 of 5 stars$0.95+8.6%$6.00+531.4%-78.9%$13.30MN/A0.0020Short Interest ↓News CoverageUPXIUpexi0.9718 of 5 stars$9.89+330.0%N/A+9.4%$13.07M$18.63M0.00130Short Interest ↑High Trading VolumeIMNNImunon2.7247 of 5 stars$0.89-0.2%$21.50+2,319.8%-35.9%$12.99M$500,000.00-0.4730Short Interest ↓ Related Companies and Tools Related Companies ABVC Competitors NRSN Competitors COCP Competitors PHIO Competitors INAB Competitors CLRB Competitors ME Competitors MBRX Competitors UPXI Competitors IMNN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBFM) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SBFM Stock Free SBFM Stock Alerts